The Gastric Cancer Treatment Controversy
- 15 June 2003
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (12), 2234-2236
- https://doi.org/10.1200/jco.2003.91.138
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Randomized Trial of Adjuvant Chemotherapy With Mitomycin, Fluorouracil, and Cytosine Arabinoside Followed by Oral Fluorouracil in Serosa-Negative Gastric Cancer: Japan Clinical Oncology Group 9206–1Journal of Clinical Oncology, 2003
- Genomic profiling of gastric cancer predicts lymph node status and survivalOncogene, 2003
- Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatmentAnnals of Surgical Oncology, 2002
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- Extended Lymph-Node Dissection for Gastric CancerThe New England Journal of Medicine, 1999
- Should systematic lymph node dissection be recommended for gastric cancer? Pro:European Journal of Cancer, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patientsThe Lancet, 1995
- Lymph Node MetastasesArchives of Surgery, 1984
- Self-evaluation in current oncologic literatureInternational Journal of Radiation Oncology*Biology*Physics, 1982